We studied the effects of recombinant human interleukin-4 (IL-4) on colony formation by enriched hematopoietic progenitors. IL-4 alone did not support colony formation at all. When IL-4 was combined with granulocyte colony-stimulating factor (G-CSF), the number of pure neutrophil colonies increased three times over that supported by G-CSF alone. I L 4 added 5 days after the addition of G-CSF failed to exert this synergistic effect, indicating that IL-4 acts on the early stage of proliferation. The mapping experiments (sequential observation of colony formation) have clearly shown that IL-4 did not initiate progenitor cell proliferation. Based on these data, IL-4 may possess a direct action on progenitor cells; however, it can only act as a costimulant with G-CSF. In contrast, I L 4 had possible inhibitory effects on macrophage colony formation supported by interleukin-3 -CELL STIMULATORY factor-I (BSF-l), also termed B interleukin-4 (IL-4), was defined as a costimulating factor for the anti-IgM antibody-induced proliferation of resting B cells.'.2 Recently, this cytokine has been shown to have multiple functional activities when tested with B cells, T cells, and macrophages.'.' Independently, IL-4 was identified as a mast cell growth factor' and, more recently, as a specific factor for the proliferation of connective tissue type mast cells. O In addition, Peschel et all' have reported that purified murine IL-4 derived from activated EL-4 cells has significant effects on hematopoietic progenitor cells. It enhances granulocyte/macrophage colony formation (CFU-GM) in the presence of granulocyte colony-stimulating factor (G-CSF), and erythroid-burst formation (BFU-E) and mixed colony formation (CFU-Mix) in the presence of erythropoietin (Ep). Rennick et all2 have also reported that purified recombinant murine IL-4 enhances erythroid, granulocyte, macrophage, and mast cell colony formation in the presence of Ep, G-CSF, macrophage colony-stimulating factor (M-CSF), and interleukin-3 (JL-3). Most recently, Broxmeyer et all3 found synergistic effects between purified recombinant human or murine IL-4 with G-CSF and Ep on the proliferation of myeloid and erythroid progenitor cells, respectively.
In this study, we have investigated the biologic activities of recombinant human IL-4 on enriched hematopoietic progenitor cells using human bone marrow null cells (1,000 per dish) as target cells in order to minimize in situ production of CSFs. IL-4 significantly enhanced pure neutrophil colony formation in the presence of G-CSF, as reported previ~usly."-'~ Unlike earlier reports, it did not show any ability to support the growth of erythroid bursts or mixed-colony forming cells. Our results indicate that IL-4 induces progenitor cells to become more sensitive to G-CSF and, therefore, predominantly induces neutrophil differentiation. We propose that IL-4 supports early stages of proliferation of hematopoietic progenitors, but that its primary targets are more mature than those of either IL-3 or GM-CSF. 
MATERIALS AND METHODS
Purified bacterially derived recombinant human interleukin-3 (IL-3) was a generous gift of the Bacterial Expression Laboratories of the Genetics Institute (Cambridge, MA) and had a specific activity of 2 x lo7 U/mg.I4 GM-CSF was purified from media conditioned by Chinese hamster ovary (CHO) cells engineered to express human GM-CSF, as described previously. 15 Purified CHO cell-derived Ep had a specific activity of 190,000 U/mg. CHO cell-derived M-CSF was 50% pure, and the source of G-CSF was a crude conditioned medium (CM) of CHO cells expressing human G-CSF. IL-4 was a crude CM produced by COS-cells that had been transfected with cDNA encoding human IL-4 and gave half-maximal activity in the chronic myelogenous leukemia (CML) blast proliferation assay at a final concentration of 1 : 13,000 dilution. These recombinant factors were kindly provided by Dr Steven C. Clark of the Genetics Institute. For part of the experiments, we used purified recombinant human IL-4 and G-CSF.
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containing 400 U of preservative-free heparin (Shimizu Pharmaceutical, Osaka, Japan). Mononuclear cells were separated using Ficoll-Paque (Pharmacia, Piscataway, NJ) density gradient centrifugation, and nonadherent cells were recovered by overnight adherence to plastic dishes. The mononuclear nonadherent (MNNA) cell fractions were further enriched for null cell fractions using nylon fiber column (Wako Pure Chemical, Osaka, Japan) and rosette formation with neuraminidase-treated sheep erythrocytes as reported elsewhere." For part of the experiments, peripheral blood null cell fractions were separated as bone marrow cells.
Cultures were carried out in 35 mm Lux suspension culture dishes (#5221 R, Miles Scientific, Naperville, IL) by using a modification of the technique originally reported by Iscove et a1." One milliliter of culture contained 1,000 bone marrow null cells or 1 x lo4 peripheral blood null cells, 1.2% of 1,500 centipoise methylcellulose (Shinetsu Chemical, Tokyo, Japan), 30% fetal calf serum (FCS), 1% crystallized and deionized bovine serum albumin (BSA; Sigma Chemical Co, St Louis, MO), 5 x mol/L mercaptoethanol (Sigma), and one or more recombinant human CSFs. The MNNA cell fractions were used for the titration experiment of recombinant human IL-4. Final concentrations of each CSF were as follows: IL-3, 100 U/mL; GM-CSF, 100 U/mL; G-CSF, 1: 1,000 dilution of CHO cell CM; M-CSF, 1:1,000 dilution of CHO cell CM; and Ep, 2 U/mL. These concentrations supported maximal total colony formation, as we reported previously.'' In part of the experiments, we used purified CHO cell-derived G-CSF. Ten nanograms of G-CSF supported maximal neutrophil colony formation in the titration experiment (data not shown). Dishes were incubated at 37OC in a fully humidified atmosphere flushed with a combination of 5% C02, 5% Olr and 90% N,. On day 12 to day 14 of incubation, all colonies were scored in situ on an inverted microscope. Colony types identified in situ were granulocyte (G), macrophage (M), granulocyte/macrophage (GM), eosinophil (EO), and erythrocyte-containing mixed colony (E-Mix). For morphologic analysis, granulocyte colonies were picked with a 3 pL Eppendorf micropipette and stained with May-Grunwald Giemsa.
The significance of the differences of means was determined using the two-tailed Student's t test. Table 1 . IL-4 induced neutrophil colony formation in the presence of G-CSF. On the other hand, concentrations up to 1:lOO dilution of supernatant did not show any effect on colony formation supported by Ep alone (data not shown). Based on these data, we chose a 1:1,000 dilution of supernatant as the standard concentration of IL-4 in the following experiments.
Clonal cell culture.
Statistical analysis.
RESULTS
Dose
Effects of IL-4 on colony formation supported by terminally acting CSFs andlor stage-specific CSFs. Next we examined the effects of IL-4 on colony formation supported by terminally acting CSFs such as G-CSF, M-CSF, and Ep" and combinations of these CSFs with IL-3. The results of representative experiments are shown in Table 2 . IL-4 alone did not support significant colony formation. When G-CSF and IL-4 were combined, the number of neutrophil colonies was three times more than that with G-CSF alone or with IL-3 plus G-CSF or with a combination of five CSFs. IL-4 had no effect on macrophage colony formation in the presence of M-CSF. Also, the combination of IL-4 and Ep yielded almost the same number of erythroid bursts as that supported by Ep alone. Additionally, IL-4 and Ep did not support erythrocyte-containing mixed colonies. On the other hand, IL-3 and Ep supported almost the same number of erythroid bursts and mixed colonies as did a combination of five CSFs. Then we used peripheral blood null cells as a target population to determine if IL-4 has any effect on erythroid burst formation. The results are presented in Table   3 . In this experiment, concentrations up to 1:lOO dilution of supernatant containing IL-4 did not support any erythroid burst formation over that supported by Ep alone. However, in the same experiment, IL-3 exhibited potent burst-promoting activity (BPA). These results clearly demonstrated that IL-4 does not have significant BPA.
Next, we tested the effects of IL-4 on colony formation supported by stage-specific CSFs such as IL-3 or GM-CSF alone." We found no effects on colony formation supported by these factors (data not shown).
Efects of IL-4 on colony formation supported by various combinations of CSFs. In order to delineate the actions of IL-4 on colony formation, we studied the effects of various combinations of CSFs with or without IL-4. As shown in Table 4 , a combination of G-CSF and IL-4 again showed remarkable synergistic action on neutrophil colony forma- For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Table 5 . Colony formation supported by day 0 G-CSF followed by day 5 IL-4 did not show synergistic action. However, when G-CSF was added on day 5 to separate experiment, we further tested the synergistic effects cultures containing IL-4 from day 0, the number of neutroof IL-4 with GM-CSF. IL-4 did not synergize with GM-CSF phil colonies increased three times higher than that supin the absence of Ep. In addition, the numbers of erythroid ported by G-CSF alone, as described previously. To characbursts or erythrocyte-containing mixed colonies supported by terize this action in more detail, we carried out a "mapping IL-4, GM-CSF, and Ep were almost the same as those experiment," which is sequential observation of colony formasupported by GM-CSF and Ep (data not shown). On the tion in culture. In this experiment, we first identified small other hand, IL-4 expressed significant inhibitory activity clusters of cells and recorded the area of the clusters in the against pure macrophage colony formation supported either dish. Subsequent growth of the clusters was recorded. The by a combination of IL-3 and M-CSF or a combination of results are presented in Fig 1. In this experiment, dishes were five CSFs. examined on days 5, 7, 10, and 13 with an inverted Effects of delayed addition of IL-4 or G-CSF on colony microscope. From day 5 to day 10, over 40 small clusters formation. In order to further clarify the mechanism of the containing fewer than 15 immature cells were identified; synergistic action of IL-4 with G-CSF, we performed dehowever, most of these disappeared by the next observation layed addition experiments using two different approaches.
time. On day 13, only three small macrophage colonies were seen; no other active cell proliferation was observed. If G-CSF was added to these cultures on day 5, however, significant proliferation of neutrophil colonies began (data not shown). Next, we compared IL-3 and IL-4 for the ability to maintain erythroid progenitors (BFU-E) and multipotential progenitors (CFU-Mix) in culture. Peripheral blood null cells (1 x lo4) were cultured for 5 days in the presence of either IL-4 or IL-3 alone. On day 5 of incubation, G-CSF and Ep were carefully overlayed, and colonies were enumerated on day 14. As shown in Table 6 , approximately 80% of erythroid burst and all of mixed colonies survived in the presence of IL-3. By contrast, IL-4 could not support the survival of erythroid burst nor mixed colony forming cells.
Only neutrophil colony forming cells survived and recovered after the delayed addition of G-CSF and Ep.
Colony formation supported by purijied IL-4 in the presence of G-CSF or Ep. Although we used a plateaurange dilution of the IL-kontaining COS-cell supernatant, inhibitors for erythroid burst or mixed colony formation may have been present in the C M and may have affected the synergistic action. We therefore tested the effects of various concentrations (1 to 2,000 U/mL) of highly purified C H O cell-derived IL-4 on colony formation in the presence of G-CSF or Ep ( Table 7) . In this experiment, we also used purified CHO cell-derived G-CSF instead of a crude C M containing G-CSF. One unit per milliliter (0.2 ng/mL) of IL-4 again showed a distinct synergistic action with G-CSF For on neutrophil colony formation. Over 10 U/mL (2 ng/mL) of IL-4 revealed the maximal synergistic effect with G-CSF. By contrast, concentrations up to 2,000 U (400 ng/mL) of IL-4 did not show significant BPA or mixed colony supporting ability in the presence of Ep.
DISCUSSION
Several investigators have documented the unique actions of IL-4 on hematopoietic progenitor cells. Peschel et al"
reported the costimulating effects of purified murine IL-4 with G-CSF or Ep, generating enhanced proliferations of CFU-GM, CFU-E, BFU-E, and CFU-Mix. It is also effective as a megakaryocyte-stimulating factor in combination with IL-1, Ep, or supernatants of a T-cell hybridoma. Rennick et allz also reported the same enhancing effects of recombinant murine IL-4 on erythroid, granulocyte, macrophage, and mast cell colony formation, when used as costimulant with factors such as Ep, G-CSF, M-CSF, and IL-3. When highly purified Thy-ll"+ cells were used as target cells, the effect of IL-4 on colony formation supported by IL-3 has been somewhat controversial. In this culture system, IL-4 suppressed colony formation not only by CFU-GM, but also by CFU-Mix. Most recently, Broxmeyer et all3 has reported that recombinant human 1L-4 also enhanced neutrophil and erythroid colony formation supported by either G-CSF or Ep in relatively high density cultures, as has been reported in murine culture systems. They proposed that IL-4 augmented the release of G-CSF, CSF-1, or GM-CSF from macrophages and/or T cells a t low concentration, and tumor necrosis factor-a from macrophages at higher concentration, suggesting an indirect mechanism of action for IL-4.
We investigated the effects of recombinant human IL-4 on colony formation by enriched human hematopoietic progenitor cells at low cell density. IL-4 alone did not support colony formation. However, IL-4 did markedly enhance pure neutrophil colony formation in the presence of G-CSF. As shown by the delayed addition experiment, this synergistic effect required the presence of IL-4 from the initial day of culture. in the murine system appears to directly increase the sensitivity of progenitor cells to G-CSF, thereby promoting differentiation along the neutrophil pathway. The other effects of IL-4 are likely to be indirect.
Our previous report suggested that the primary targets of IL-3 and GM-CSF are multipotential progenitors a t the early and intermediate stages of development.20 IL-3 can synergistically act with terminally acting CSFs such as G-CSF, EP,~' and IL-5" in support of neutrophil, erythroid, and eosinophil colony formation, respectively. In addition, IL-3 can initiate the proliferation of early multipotential progenitors.20 In contrast, IL-4 could support neither proliferation nor survival of erythroid burst or mixed colony forming cells, as shown by the delayed addition experiment and mapping study and demonstrating apparent differences between functions of human IL-4 and IL-3. Broxmeyer et aI,l3 however, have reported apparent BPA of recombinant human IL-4. This discrepancy may be due to the cell concentration in cultures. In their relatively high density culture, IL-4 may have stimulated macrophages Or T cells to release cytokines with BPA, such as GM-CSF or IL-3. In most experiments, we used a COS-cell conditioned medium con-U/mL), G-CSF (20 ng/mL), and Ep (2 U/mL). Abbreviations defined in legend to Table 1. taining IL-4. Therefore, we tested the effects of highly purified IL-4 on colony formation supported by either G-CSF or Ep and found the same synergistic action of IL-4 with G-CSF. Again purified IL-4 did not synergize with Ep in support of erythroid burst or mixed colony formation.
Recently, Kishi et alz3 have shown that purified recombinant murine IL-4 directly acts on multipotential blast cell colonies to generate granulocyte/erythrocyte/macrophage/ megakaryocyte (GEMM) colonies. However, we failed to find stimulatory effects of recombinant human IL-4 on erythroid burst and mixed colony forming cells. This suggests the possibility that IL-4 may behave differently in the human and murine systems. Alternatively, the discrepancies in the results may reflect differences in target populations, as well as the presence or absence of accessory cells that may modify the activities of IL-4 in culture.
